Beta Bionics Details iLet Automation Strategy, Sales Expansion and Mint Patch Pump Timeline at Conference

Beta Bionics (NASDAQ: BBNX) executives used a conference presentation to outline the company's strategy in insulin delivery, emphasizing automation, pharmacy reimbursement, and an expanding commercial footprint as key pillars of its growth plan. Positioning iLet around "automation-forward" insulin delivery Chief Financial Officer Stephen Feider described Beta Bionics' iLet insulin pump as differentiated primarily by its approach